0.9 |
2.6 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
0.8 |
3.1 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.5 |
2.4 |
GO:0042117 |
monocyte activation(GO:0042117) |
0.4 |
1.2 |
GO:0072299 |
negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.4 |
1.2 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.4 |
1.6 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
0.4 |
1.1 |
GO:1904980 |
regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.3 |
1.8 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
0.3 |
0.3 |
GO:0072166 |
posterior mesonephric tubule development(GO:0072166) |
0.3 |
0.8 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 |
1.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.3 |
0.8 |
GO:2000979 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.3 |
1.0 |
GO:0003360 |
brainstem development(GO:0003360) |
0.3 |
0.8 |
GO:2000597 |
optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.3 |
1.0 |
GO:0035128 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.2 |
1.2 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 |
0.9 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
0.2 |
0.5 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 |
0.9 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
0.2 |
0.2 |
GO:2000137 |
negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.2 |
0.2 |
GO:0099404 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.2 |
1.7 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
0.2 |
0.6 |
GO:0002588 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.2 |
1.4 |
GO:0072081 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.2 |
0.6 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
0.2 |
1.0 |
GO:0071104 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
0.2 |
0.6 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
0.2 |
0.6 |
GO:0072004 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) |
0.2 |
0.8 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
0.2 |
0.7 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
0.2 |
0.7 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.2 |
1.3 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 |
1.0 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
0.2 |
0.7 |
GO:0045636 |
positive regulation of melanocyte differentiation(GO:0045636) |
0.2 |
1.7 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
0.2 |
0.7 |
GO:1904800 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
0.2 |
0.2 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
0.2 |
0.2 |
GO:0072309 |
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.2 |
1.8 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
0.2 |
1.3 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 |
0.6 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
0.2 |
0.8 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
0.2 |
0.5 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 |
0.3 |
GO:0071317 |
cellular response to isoquinoline alkaloid(GO:0071317) |
0.2 |
0.5 |
GO:1900045 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 |
0.7 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 |
0.1 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
0.1 |
0.6 |
GO:0061010 |
gall bladder development(GO:0061010) |
0.1 |
1.4 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 |
0.4 |
GO:0021998 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 |
0.5 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
0.1 |
0.4 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.1 |
0.5 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 |
0.1 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 |
0.4 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 |
0.5 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 |
1.4 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 |
0.1 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 |
0.9 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
0.1 |
1.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
0.1 |
0.6 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
0.1 |
1.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 |
0.1 |
GO:0035502 |
metanephric part of ureteric bud development(GO:0035502) |
0.1 |
0.8 |
GO:1901300 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.1 |
0.7 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
0.1 |
0.5 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
0.1 |
1.0 |
GO:0002432 |
granuloma formation(GO:0002432) |
0.1 |
0.7 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
0.1 |
0.3 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 |
0.4 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.1 |
4.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
0.1 |
1.2 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 |
0.2 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.1 |
0.4 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 |
0.2 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 |
0.8 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
0.1 |
0.3 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
0.1 |
0.2 |
GO:0019042 |
viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.1 |
0.3 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.1 |
0.3 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.1 |
0.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
0.1 |
0.1 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 |
0.2 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
0.1 |
0.4 |
GO:0060032 |
notochord regression(GO:0060032) |
0.1 |
0.4 |
GO:2000705 |
negative regulation of anion channel activity(GO:0010360) regulation of dense core granule biogenesis(GO:2000705) |
0.1 |
0.2 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
0.1 |
0.4 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
0.1 |
0.4 |
GO:0048382 |
mesendoderm development(GO:0048382) |
0.1 |
1.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 |
0.1 |
GO:0003133 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.1 |
0.3 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 |
0.3 |
GO:0045660 |
positive regulation of neutrophil differentiation(GO:0045660) |
0.1 |
0.4 |
GO:2001166 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 |
0.2 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 |
0.4 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 |
0.4 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
0.1 |
0.3 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
0.1 |
0.4 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 |
0.3 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
0.1 |
1.0 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 |
1.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
0.1 |
0.4 |
GO:1903758 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 |
0.3 |
GO:0071462 |
cellular response to water stimulus(GO:0071462) |
0.1 |
0.6 |
GO:0007296 |
vitellogenesis(GO:0007296) |
0.1 |
0.1 |
GO:0098917 |
retrograde trans-synaptic signaling(GO:0098917) |
0.1 |
0.3 |
GO:0030221 |
basophil differentiation(GO:0030221) |
0.1 |
0.2 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
0.1 |
0.6 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 |
1.2 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
0.1 |
0.2 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
0.1 |
0.9 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
0.1 |
0.7 |
GO:0009644 |
response to high light intensity(GO:0009644) |
0.1 |
0.2 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 |
0.6 |
GO:0070495 |
regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 |
0.1 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
0.1 |
0.1 |
GO:0032907 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.1 |
0.3 |
GO:0051581 |
negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 |
0.3 |
GO:0035483 |
gastric emptying(GO:0035483) |
0.1 |
0.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 |
0.7 |
GO:0032264 |
IMP salvage(GO:0032264) |
0.1 |
0.1 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.1 |
0.2 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.1 |
0.2 |
GO:0045626 |
negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 |
0.2 |
GO:1900157 |
regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 |
0.3 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
0.1 |
0.2 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
0.1 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 |
0.2 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 |
0.1 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
0.1 |
0.5 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
0.1 |
0.2 |
GO:0061090 |
positive regulation of sequestering of zinc ion(GO:0061090) |
0.1 |
0.1 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 |
0.2 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 |
0.3 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
0.1 |
0.3 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
0.1 |
0.3 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 |
0.8 |
GO:0099628 |
receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.1 |
0.4 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
0.1 |
0.3 |
GO:0042938 |
dipeptide transport(GO:0042938) |
0.1 |
0.1 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
0.1 |
0.7 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 |
0.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
0.1 |
0.6 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
0.1 |
0.5 |
GO:0015074 |
DNA integration(GO:0015074) |
0.1 |
0.5 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 |
0.1 |
GO:1904306 |
positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.1 |
0.3 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 |
0.2 |
GO:0051385 |
response to mineralocorticoid(GO:0051385) |
0.1 |
1.7 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 |
0.2 |
GO:0045041 |
positive regulation of T cell mediated immune response to tumor cell(GO:0002842) protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 |
1.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 |
0.1 |
GO:0036016 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 |
0.2 |
GO:1903028 |
regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.1 |
0.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
0.1 |
0.3 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
0.1 |
0.3 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
0.1 |
0.4 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
0.1 |
0.4 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 |
0.5 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
0.1 |
0.4 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) |
0.1 |
0.3 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
0.1 |
0.3 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
0.1 |
0.9 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 |
1.0 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 |
0.2 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.1 |
0.2 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
0.1 |
0.3 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) telomerase RNA stabilization(GO:0090669) |
0.1 |
0.2 |
GO:1905053 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 |
0.5 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
0.1 |
0.7 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 |
0.2 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
0.1 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
0.1 |
0.4 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
0.1 |
0.3 |
GO:0039536 |
regulation of RIG-I signaling pathway(GO:0039535) negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 |
0.4 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
0.1 |
0.2 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 |
0.2 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
0.1 |
0.3 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.1 |
0.1 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
0.1 |
0.1 |
GO:0060685 |
regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.1 |
0.4 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 |
0.1 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
0.1 |
0.4 |
GO:0072553 |
terminal button organization(GO:0072553) |
0.1 |
0.2 |
GO:0061743 |
motor learning(GO:0061743) |
0.1 |
0.3 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 |
0.1 |
GO:0002277 |
myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 |
0.2 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
0.1 |
0.2 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
0.1 |
0.2 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
0.1 |
0.2 |
GO:1902966 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 |
0.4 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
0.1 |
0.1 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) |
0.1 |
0.3 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
0.1 |
1.2 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
0.0 |
0.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
0.0 |
0.5 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 |
0.3 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 |
0.3 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 |
0.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
0.0 |
0.4 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
0.0 |
0.3 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 |
0.1 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.0 |
0.2 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
0.0 |
0.4 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.0 |
0.2 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 |
0.2 |
GO:0035989 |
tendon development(GO:0035989) |
0.0 |
0.3 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
0.0 |
0.2 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
0.0 |
0.2 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
0.0 |
0.2 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 |
0.1 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
0.0 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
0.0 |
0.1 |
GO:0021563 |
glossopharyngeal nerve development(GO:0021563) |
0.0 |
0.3 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.0 |
0.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
0.0 |
0.5 |
GO:2000169 |
regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 |
0.1 |
GO:0002305 |
gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 |
0.6 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 |
0.2 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
0.0 |
0.1 |
GO:0009726 |
detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.0 |
0.4 |
GO:1904261 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 |
0.2 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
0.0 |
0.1 |
GO:0014858 |
positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.0 |
0.2 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.0 |
0.9 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
0.0 |
0.2 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 |
0.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
0.0 |
0.2 |
GO:0035993 |
subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) superior vena cava morphogenesis(GO:0060578) |
0.0 |
0.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 |
0.1 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
0.0 |
0.1 |
GO:1900223 |
positive regulation of beta-amyloid clearance(GO:1900223) |
0.0 |
0.3 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
0.0 |
0.4 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
0.0 |
0.2 |
GO:0051012 |
microtubule sliding(GO:0051012) |
0.0 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
0.0 |
0.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
0.0 |
0.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 |
0.2 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 |
0.4 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
0.0 |
0.1 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 |
0.5 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 |
0.0 |
GO:0007208 |
phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.0 |
0.1 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 |
0.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 |
0.2 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 |
0.0 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 |
0.1 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 |
0.1 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.0 |
0.2 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
0.0 |
0.0 |
GO:2000860 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 |
0.2 |
GO:0072133 |
kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 |
0.3 |
GO:0099633 |
protein localization to postsynaptic specialization membrane(GO:0099633) neurotransmitter receptor localization to postsynaptic specialization membrane(GO:0099645) |
0.0 |
0.9 |
GO:0007625 |
grooming behavior(GO:0007625) |
0.0 |
0.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 |
0.1 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
0.0 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 |
0.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
0.0 |
0.4 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
0.0 |
0.0 |
GO:0048022 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 |
0.1 |
GO:0009804 |
coumarin metabolic process(GO:0009804) dibenzo-p-dioxin metabolic process(GO:0018894) |
0.0 |
0.4 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 |
0.2 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
0.0 |
0.2 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) |
0.0 |
0.4 |
GO:0097461 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 |
0.2 |
GO:0006868 |
glutamine transport(GO:0006868) |
0.0 |
0.6 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 |
1.0 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.0 |
1.0 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 |
0.0 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.0 |
0.3 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
0.0 |
0.4 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
0.0 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
0.0 |
0.0 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 |
0.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
0.0 |
0.7 |
GO:0001967 |
suckling behavior(GO:0001967) |
0.0 |
0.2 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
0.0 |
0.3 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 |
0.0 |
GO:2001271 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 |
0.2 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
0.0 |
0.5 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 |
0.1 |
GO:0003195 |
tricuspid valve formation(GO:0003195) |
0.0 |
0.1 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.0 |
0.3 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
0.0 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
0.0 |
0.9 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
0.0 |
0.2 |
GO:2000327 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 |
0.1 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
0.0 |
0.4 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
0.0 |
0.4 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
0.0 |
0.1 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) monocyte extravasation(GO:0035696) interleukin-15-mediated signaling pathway(GO:0035723) activation of meiosis involved in egg activation(GO:0060466) cellular response to interleukin-15(GO:0071350) response to fluoride(GO:1902617) regulation of monocyte extravasation(GO:2000437) |
0.0 |
0.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
0.0 |
1.2 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 |
0.4 |
GO:0035278 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 |
0.1 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
0.0 |
0.5 |
GO:1901898 |
negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 |
0.1 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 |
0.2 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.0 |
0.0 |
GO:0072284 |
comma-shaped body morphogenesis(GO:0072049) metanephric S-shaped body morphogenesis(GO:0072284) |
0.0 |
0.3 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
0.0 |
1.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
0.0 |
0.5 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
0.0 |
0.4 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
0.0 |
0.2 |
GO:0009650 |
UV protection(GO:0009650) |
0.0 |
0.1 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.0 |
0.3 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
0.0 |
0.2 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) cellular response to temperature stimulus(GO:0071502) |
0.0 |
0.2 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
0.0 |
0.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
0.0 |
0.1 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
0.0 |
0.1 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.0 |
0.3 |
GO:0044062 |
regulation of excretion(GO:0044062) |
0.0 |
0.3 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
0.0 |
0.4 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 |
0.2 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
0.0 |
0.2 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
0.0 |
0.3 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 |
0.0 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
0.0 |
0.3 |
GO:2000467 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 |
0.2 |
GO:0045356 |
positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 |
0.1 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
0.0 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
0.0 |
0.7 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
0.0 |
0.1 |
GO:0060618 |
nipple development(GO:0060618) |
0.0 |
0.5 |
GO:0007588 |
excretion(GO:0007588) |
0.0 |
0.1 |
GO:0051794 |
regulation of catagen(GO:0051794) |
0.0 |
0.2 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
0.0 |
0.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 |
0.3 |
GO:0021815 |
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.0 |
0.3 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 |
0.0 |
GO:0060166 |
olfactory pit development(GO:0060166) |
0.0 |
0.1 |
GO:0097252 |
negative regulation of interleukin-13 production(GO:0032696) oligodendrocyte apoptotic process(GO:0097252) |
0.0 |
0.3 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 |
0.1 |
GO:0001806 |
type IV hypersensitivity(GO:0001806) |
0.0 |
0.2 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
0.0 |
0.4 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
0.0 |
0.1 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 |
0.1 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.0 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
0.0 |
0.3 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 |
0.2 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
0.0 |
0.2 |
GO:1905206 |
positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.0 |
0.1 |
GO:1902564 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
0.0 |
0.1 |
GO:2000586 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
0.0 |
0.1 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 |
0.5 |
GO:0045056 |
transcytosis(GO:0045056) |
0.0 |
0.1 |
GO:0072619 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
0.0 |
0.1 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.0 |
0.2 |
GO:0014004 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.0 |
0.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
0.0 |
0.2 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
0.0 |
0.2 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
0.0 |
0.1 |
GO:1990839 |
response to endothelin(GO:1990839) |
0.0 |
0.4 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
0.0 |
0.2 |
GO:0035879 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 |
0.1 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
0.0 |
0.1 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
0.0 |
0.4 |
GO:0015747 |
urate transport(GO:0015747) |
0.0 |
0.8 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 |
0.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
0.0 |
0.2 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 |
0.1 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
0.0 |
0.2 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 |
0.1 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
0.0 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
0.0 |
0.1 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
0.0 |
0.1 |
GO:0003218 |
cardiac left ventricle formation(GO:0003218) |
0.0 |
0.1 |
GO:2001201 |
regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 |
0.4 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
0.0 |
0.2 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
0.0 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
0.0 |
0.4 |
GO:0015816 |
glycine transport(GO:0015816) |
0.0 |
0.1 |
GO:0030859 |
polarized epithelial cell differentiation(GO:0030859) |
0.0 |
0.1 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 |
0.3 |
GO:0071435 |
potassium ion export(GO:0071435) |
0.0 |
0.1 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
0.0 |
0.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
0.0 |
0.1 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
0.0 |
0.2 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 |
0.0 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
0.0 |
0.1 |
GO:1903296 |
regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.0 |
0.2 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
0.0 |
0.0 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
0.0 |
0.0 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
0.0 |
0.0 |
GO:0043382 |
positive regulation of memory T cell differentiation(GO:0043382) |
0.0 |
0.0 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
0.0 |
0.1 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
0.0 |
0.1 |
GO:0075509 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 |
0.1 |
GO:1901738 |
regulation of vitamin A metabolic process(GO:1901738) |
0.0 |
0.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
0.0 |
0.0 |
GO:2000293 |
regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.0 |
0.2 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 |
0.3 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
0.0 |
0.2 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
0.0 |
0.0 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
0.0 |
0.4 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
0.0 |
0.1 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 |
0.6 |
GO:0038066 |
p38MAPK cascade(GO:0038066) |
0.0 |
0.1 |
GO:0003096 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
0.0 |
0.1 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
0.0 |
0.1 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 |
0.1 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
0.0 |
0.1 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
0.0 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
0.0 |
0.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
0.0 |
0.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
0.0 |
0.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
0.0 |
0.3 |
GO:2000400 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 |
0.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 |
0.1 |
GO:0010909 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.0 |
0.0 |
GO:0021524 |
visceral motor neuron differentiation(GO:0021524) |
0.0 |
0.1 |
GO:0036414 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 |
0.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
0.0 |
0.4 |
GO:0044783 |
G1 DNA damage checkpoint(GO:0044783) |
0.0 |
0.3 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 |
0.1 |
GO:0001759 |
organ induction(GO:0001759) |
0.0 |
0.2 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 |
0.0 |
GO:0036215 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.0 |
0.1 |
GO:0034727 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
0.0 |
0.1 |
GO:0061438 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.0 |
0.1 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
0.0 |
1.8 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
0.0 |
0.2 |
GO:0002826 |
negative regulation of T-helper 1 type immune response(GO:0002826) |
0.0 |
0.0 |
GO:2000016 |
negative regulation of determination of dorsal identity(GO:2000016) |
0.0 |
0.1 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.0 |
0.2 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
0.0 |
0.1 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 |
0.1 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
0.0 |
0.2 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
0.0 |
0.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 |
0.4 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
0.0 |
0.1 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
0.0 |
0.2 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 |
0.1 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
0.0 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.0 |
0.1 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
0.0 |
0.1 |
GO:0030910 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
0.0 |
0.1 |
GO:2001280 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 |
0.0 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
0.0 |
0.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.0 |
0.1 |
GO:0001970 |
positive regulation of activation of membrane attack complex(GO:0001970) |
0.0 |
0.0 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
0.0 |
0.2 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 |
0.4 |
GO:0007143 |
female meiotic division(GO:0007143) |
0.0 |
0.5 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
0.0 |
0.9 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
0.0 |
0.1 |
GO:0061072 |
voluntary musculoskeletal movement(GO:0050882) iris morphogenesis(GO:0061072) |
0.0 |
0.1 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 |
0.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
0.0 |
0.3 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 |
0.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 |
0.1 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
0.0 |
0.3 |
GO:0003299 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 |
0.1 |
GO:0030432 |
peristalsis(GO:0030432) |
0.0 |
0.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 |
0.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
0.0 |
0.1 |
GO:1904378 |
maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 |
0.3 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
0.0 |
0.1 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
0.0 |
0.1 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
0.0 |
0.1 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
0.0 |
0.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
0.0 |
0.0 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 |
0.1 |
GO:0090148 |
membrane fission(GO:0090148) |
0.0 |
0.0 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
0.0 |
0.1 |
GO:0002225 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 |
0.1 |
GO:0015862 |
uridine transport(GO:0015862) |
0.0 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
0.0 |
0.6 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
0.0 |
1.0 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 |
0.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 |
0.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
0.0 |
0.1 |
GO:0090472 |
dibasic protein processing(GO:0090472) |
0.0 |
0.1 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 |
0.1 |
GO:0034351 |
negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 |
1.7 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
0.0 |
0.0 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 |
0.2 |
GO:0036065 |
fucosylation(GO:0036065) |
0.0 |
0.0 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
0.0 |
0.1 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 |
0.0 |
GO:0098971 |
anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.0 |
0.2 |
GO:0006968 |
cellular defense response(GO:0006968) |
0.0 |
0.0 |
GO:0033577 |
protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.0 |
0.1 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
0.0 |
0.3 |
GO:0050913 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) sensory perception of bitter taste(GO:0050913) |
0.0 |
0.1 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 |
0.0 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.0 |
0.1 |
GO:0033058 |
directional locomotion(GO:0033058) |
0.0 |
0.0 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
0.0 |
0.1 |
GO:0030242 |
pexophagy(GO:0030242) |
0.0 |
0.0 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
0.0 |
0.1 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 |
0.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 |
0.0 |
GO:0042796 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 |
0.0 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
0.0 |
0.1 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 |
0.1 |
GO:0015871 |
choline transport(GO:0015871) |
0.0 |
0.1 |
GO:1904587 |
response to glycoprotein(GO:1904587) |
0.0 |
0.4 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
0.0 |
0.0 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
0.0 |
0.3 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
0.0 |
0.1 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
0.0 |
0.1 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
0.0 |
0.2 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
0.0 |
0.1 |
GO:0070268 |
cornification(GO:0070268) |
0.0 |
0.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 |
0.0 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
0.0 |
0.0 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 |
0.4 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
0.0 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 |
0.0 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
0.0 |
0.0 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 |
0.2 |
GO:0060065 |
uterus development(GO:0060065) |
0.0 |
0.0 |
GO:0007512 |
adult heart development(GO:0007512) |
0.0 |
0.1 |
GO:0060174 |
limb bud formation(GO:0060174) |
0.0 |
0.4 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 |
0.1 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 |
0.0 |
GO:0061033 |
secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.0 |
0.8 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
0.0 |
0.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
0.0 |
0.0 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
0.0 |
0.1 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 |
0.0 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
0.0 |
0.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
0.0 |
0.1 |
GO:0006491 |
N-glycan processing(GO:0006491) |
0.0 |
0.1 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 |
0.0 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
0.0 |
0.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
0.0 |
0.1 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
0.0 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
0.0 |
0.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 |
0.1 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
0.0 |
0.1 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 |
0.5 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
0.0 |
0.0 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
0.0 |
0.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
0.0 |
0.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
0.0 |
0.0 |
GO:0007199 |
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
0.0 |
0.0 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.0 |
0.0 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
0.0 |
0.1 |
GO:0045585 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 |
0.0 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
0.0 |
0.1 |
GO:0007614 |
short-term memory(GO:0007614) |
0.0 |
0.2 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
0.0 |
0.1 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
0.0 |
0.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
0.0 |
0.1 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
0.0 |
0.0 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
0.0 |
0.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
0.0 |
0.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
0.0 |
0.0 |
GO:0021660 |
rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.0 |
0.1 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.0 |
1.5 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 |
0.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
0.0 |
0.0 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
0.0 |
0.2 |
GO:0010842 |
retina layer formation(GO:0010842) |
0.0 |
0.4 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
0.0 |
0.0 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |